0001209191-16-098272.txt : 20160212
0001209191-16-098272.hdr.sgml : 20160212
20160212194631
ACCESSION NUMBER: 0001209191-16-098272
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160210
FILED AS OF DATE: 20160212
DATE AS OF CHANGE: 20160212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abney Michael Donald Jr.
CENTRAL INDEX KEY: 0001631320
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 161422096
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-10
0
0000353569
QUIDEL CORP /DE/
QDEL
0001631320
Abney Michael Donald Jr.
12544 HIGH BLUFF DRIVE, SUITE 200
SAN DIEGO
CA
92130
0
1
0
0
SVP - Distribution
Non-Qualified Stock Options
15.40
2016-02-10
4
A
0
35192
0.00
A
2026-02-10
Common Stock
35192
35192
D
Restricted Stock Units
2016-02-10
4
A
0
4805
0.00
A
Common Stock
4805
4805
D
17,596 shares will vest on the second anniversary date of the grant date, February 10, 2018. 8,798 shares will vest on the third anniversary date of the grant date, February 10, 2019. 8,798 shares will vest on the fourth anniversary date of the grant date, February 10, 2020.
Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock.
2,403 shares will vest on the second anniversary date of the grant date, February 10, 2018. 1,201 shares will vest on the third anniversary date of the grant date, February 10, 2019. 1,201 shares will vest on the fourth anniversary date of the grant date, February 10, 2020.
Robert J. Bujarski, attorney-in-fact for Michael D. Abney, Jr.
2016-02-12